Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.81), $0.13 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $583.33 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.